Curated News
By: NewsRamp Editorial Staff
October 13, 2026
US Nuclear Reports Q1 Financials, 72% Loss Reduction
TLDR
- US Nuclear cut operating losses 72% and targets 20-30% sales growth in 2027, doubling sales by 2028.
- US Nuclear filed its Q1 2026 10Q and will resume trading after Q3, following new auditor recommendations.
- US Nuclear is streamlining operations and relaunching products, aiming to serve customers better and create jobs.
- US Nuclear used four college interns to analyze its TA/Optron product line for a January 2027 relaunch.
Impact - Why it Matters
US Nuclear’s ability to file its delayed quarterly reports and reduce its operating loss by 72% signals a potential turnaround for the small-cap nuclear technology company. The growing backlog and plans to relaunch the TA/Optron product line could drive significant revenue growth, while strategic discussions about joint ventures or a buyout offer upside potential. Investors should monitor the company’s filing progress and operational execution, as these factors will determine whether it can achieve its ambitious 2027 and 2028 targets. The news matters because it highlights the challenges and opportunities facing a niche player in the nuclear sector, and provides a case study in how companies recover from reporting delays and management changes.
Summary
US Nuclear Corp (OTC: UCLE) has filed its 10Q for the first quarter of 2026 and expects to file its second-quarter report within the next 3-4 weeks, according to a recent announcement. The company’s stock will resume trading after the release of its third-quarter results, projected for the first week of December. CFO Michael Hastings explained that the delay stemmed from closing the Los Angeles operation, which led to the loss of key personnel and difficulties retrieving financial data. Additionally, the company replaced some staff at Overhoff and is implementing recommendations from a new auditor to make reporting faster and more efficient. The first-quarter close and review took about four months, far exceeding the 45-day window, but Hastings noted that things are finally falling into place.
Despite these setbacks, US Nuclear is making significant operational progress. The company hired a skilled General Manager/COO in June who is streamlining logistics, clearing backlogs, and accelerating product delivery. Backlog has grown to $1.2 million and is expected to reach $2.9 million by year-end. US Nuclear also reduced its loss from operations by over $375,000, or 72%, compared to the same period in 2025. The GM is utilizing four college interns to conduct a full marketing and product analysis of the TA/Optron product line, which had been built in LA, for a relaunch in January 2027, with hopes of adding $600,000 in revenues. The company is interviewing outsourced CPA firms to ensure timely financial reporting and has started discussions with other companies for potential joint ventures, a buyout, or a reverse merger. Management expects 2027 sales and profits to increase 20-30%, with sales doubling by 2028.
For sales and product information, contact Terry Marler or Ian Embry; for investor information, contact Jack Lennon at Chamberlain Capital or [email protected]. The original release is available on NEWMEDIAWIRE, and the company’s SEC filings, including the US Nuclear Form 10Q_March 31, 2026 and US Nuclear Form 10K_December 31, 2025, provide further details.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, US Nuclear Reports Q1 Financials, 72% Loss Reduction
